pembrolizumab
merck
['melanoma', 'pembro']
exciting esmo data, #s1801: improved event free survival for stage iii melanoma patients receiving pembro prior to/after surgery compared to adjuvant alone. is proud to have enrolled patients/supported this practice changing trial! 
Surgical Oncologist at the Huntsman Cancer Institute, University of Utah